Decoy Therapeutics Inc.

DCOY | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.07

-$0.16 (-13.01%)

At close: Oct 30, 2026, 4:00 PM ET

$1.09

+$0.02 (+1.87%)

Pre-market: Nov 2, 2026, 5:03 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-13.01%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

31.5

+4.5 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #765/1028 (Top 74%)

Full Analysis

Key Statistics

Market Data

Market Cap $569.21K

1D Range

1.05 1.23

52W Range

0.92 46.68

Valuation (TTM)

PE -0.04

PB 0.13

EV/EBITDA 0.53

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $0.00

Cash Flow

FCF Yield -1469.9%

SBC Adj. FCF Yield -1547.6%

SBC Impact -5.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | 100.0%

Dil EPS 3Y | 5Y 90.0% | 63.5%

FCF 3Y | 5Y -5.0% | 22.5%

Returns

ROA -160.5%

ROE -315.2%

ROIC -343.6%

Financial Health

Net Cash

$8.29M

Current Ratio 1.83

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning an...

Sector Healthcare

Industry Biotechnology

Employees 11

IPO Date Jan 29, 2015

Website decoytx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.